醫藥合作協議：2020-2026

本報告對全球醫藥和生物技術產業的合作協議進行了全面分析。報告面向業務拓展、授權和策略專業人士，清楚闡述了企業如何建立合作關係、協商財務條款以及在研發和商業化合作中明確責任。

本報告彙編了自2020年以來簽署的合作協議的詳細合約記錄，並總結了合作趨勢、財務結構以及主要簽署方的分析。每份協議均包含指向線上合約記錄的鏈接，並在條件允許的情況下提供原始合約文件，從而直接展現影響行業合作關係的合約內容。

無論是在評估潛在合作夥伴、對標合約條款，還是對合作策略進行盡職調查，本報告都能提供所需的數據和合約層面的信息，以支持更明智的合作決策。

主要優勢

• 顯著縮短研究時間

無需搜尋多個資料庫、新聞稿和監管文件，即可存取統一的合作協議資料庫。

• 合作協議結構基準分析

您可以了解各公司如何建構合作關係，包括開發角色、財務安排和商業化責任分擔。

• 財務合約條款分析

仔細審查有關預付款、里程碑付款和特許權使用費結構的可用數據，並對類似協議的財務價值進行基準分析。

• 存取實際合約文件

在適用情況下，本報告直接連結到美國證券交易委員會 (SEC) 的文件，方便您查看關鍵聯合開發協議背後的詳細合約條款。

• 識別最活躍的合作協議簽署公司

識別哪些製藥和生技公司在合作活動中處於領先地位，並分析其合作策略。

• 追蹤合作領域的市場趨勢

依公司、治療領域和技術類型分析合作活動，以了解合作策略的演變。

目錄

摘要整理

第一章：引言

第二章：合作協議趨勢

• 合作協議的定義
• 2020年以來的合作協議趨勢
  • 依年份
  • 依研發階段
  • 依行業
  • 依治療領域
  • 依技術
  • 最活躍的公司
• 簽訂合作協議的原因
• 合作協議的未來

第三章：合作協議架構概述

• 合作協議的結構

第四章：主要合作協議

• 主要合作協議：依金額排序

第五章 最活躍的25家合作公司

• 最活躍的25家合作公司

第六章 合作公司名錄：含合約

• 合作協議：含合約
• 合約名錄
• 合約名錄 - 依公司（A-Z）排序
• 合約名錄 - 依治療領域排序
• 合約名錄 - 依技術排序
• 關於Biopharma Research Ltd
• 當前合作關係
• 當前合約
• 近期合作報告標題

Benchmark Collaboration Partnerships Across the Global Biopharma Industry

Free report sample

The Collaboration Deals in Pharmaceuticals report provides a comprehensive analysis of partnership agreements across the global pharmaceutical and biotechnology industry. Designed for business development, licensing, and strategy professionals, the report delivers a clear view of how companies structure collaboration alliances, negotiate financial terms, and share responsibilities across R&D and commercialization partnerships.

Drawing on collaboration deals announced since 2020, the report compiles detailed deal records alongside analysis of partnering trends, financial structures, and leading dealmakers. Each transaction links to an online deal record and, where available, the original contract document-giving users direct insight into the agreements that shape industry partnerships.

Whether you are evaluating a potential partner, benchmarking deal terms, or performing due diligence on collaboration strategies, this report provides the data and contract-level visibility needed to support more informed partnership decisions.

Key Benefits

• Save Significant Research Time

Access a consolidated database of collaboration deals instead of searching multiple databases, press releases, and regulatory filings.

• Benchmark Collaboration Deal Structures

Understand how companies structure collaborative partnerships, including development roles, financial arrangements, and commercialization responsibilities.

• Analyze Financial Deal Terms

Review available data on upfront payments, milestone payments, and royalty structures to benchmark the financial value of comparable deals.

• Access Real Contract Documents

Where available, the report links directly to SEC-filed agreements, allowing you to review the detailed contractual terms behind major collaboration deals.

• Identify the Most Active Collaboration Dealmakers

See which pharmaceutical and biotechnology companies are leading collaboration activity and analyze their partnership strategies.

• Track Market Trends in Collaboration Partnerships

Analyze dealmaking activity across companies, therapeutic areas, and technology types to understand how collaboration strategies are evolving.

What's Included in the Report

Analysis of collaboration dealmaking trends since 2020

Overview of collaboration deal structures and partnering models

Review of the leading collaboration deals by disclosed value

Profiles of the most active collaboration dealmakers

A comprehensive deal directory organized by company, therapeutic area, and technology type

Links to online deal records and contract documents where available

Due Diligence Insights from Real Agreements

By reviewing actual collaboration agreements, the report helps you evaluate key contractual elements such as:

• Rights granted or optioned
• Financial payment structures
• Exclusivity provisions
• Intellectual property ownership
• Development, manufacturing, and commercialization responsibilities
• Deal duration and termination provisions
• Why This Report Matters
• Collaboration partnerships are a cornerstone of innovation in the pharmaceutical and biotechnology industries. Understanding how these alliances are structured-and how financial and operational responsibilities are negotiated-can significantly improve partnership outcomes.
• This report provides the real-world data, financial benchmarking, and contract insight needed to structure better collaboration agreements and negotiate more effectively.

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in collaboration dealmaking

• 2.1. Introduction
• 2.2. Definition of collaboration deal
• 2.3. Trends in collaboration deals since 2020
  • 2.3.1. Collaboration dealmaking by year
  • 2.3.2. Collaboration dealmaking by phase of development
  • 2.3.3. Collaboration dealmaking by industry sector
  • 2.3.4. Collaboration dealmaking by therapy area
  • 2.3.5. Collaboration dealmaking by technology type
  • 2.3.6. Collaboration dealmaking by most active company
• 2.4. Reasons for entering into collaboration partnering deals
• 2.5. The future of collaboration deals

Chapter 3 - Overview of collaboration deal structure

• 3.1. Introduction
• 3.2. Collaboration agreement structure

Chapter 4 - Leading collaboration deals

• 4.1. Introduction
• 4.2. Top collaboration deals by value

Chapter 5 - Top 25 most active collaboration dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active collaboration dealmakers

Chapter 6 - Collaboration deals including contracts directory

• 6.1. Introduction
• 6.2. Collaboration deals with contracts
• Deal directory
• Deal directory - collaboration dealmaking by companies A-Z
• Deal directory - collaboration dealmaking by therapy area
• Deal directory - collaboration dealmaking by technology type
• About Biopharma Research Ltd
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of collaboration deals
• Figure 2: Trends in collaboration deal announcements, 2020-2026
• Figure 3: Collaboration deals signed at each phase of development
• Figure 4: Collaboration deals by industry sector
• Figure 5: Collaboration deals by therapy area
• Figure 6: Collaboration deals by technology type
• Figure 7: Top 25 most active collaboration dealmakers
• Figure 8: Top collaboration deals by value
• Figure 9: Most active collaboration dealmakers